321550 — TiumBio Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩188bn
- KR₩195bn
- KR₩5bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,113 | 1,049 | 56.8 | 9,118 | 4,899 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,133 | 14,352 | 32,753 | 34,076 | 20,939 |
Operating Profit | -8,020 | -13,303 | -32,696 | -24,958 | -16,040 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7,091 | -12,119 | -32,253 | -31,402 | -19,038 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7,091 | -12,119 | -32,253 | -31,402 | -19,038 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -7,091 | -12,119 | -31,637 | -29,853 | -17,911 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -7,091 | -12,119 | -31,637 | -29,853 | -17,911 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -354 | -516 | -1,329 | -1,274 | -1,217 |
Dividends per Share |